This dual mechanism—marked by elevated vWF levels and reduced ADAMTS13 activity—disrupts hemostatic balance and can result in microvascular thrombosis, a central feature of TTP. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.